Miltenyi Biotec Identification and Enumeration of Cd309 (Vegfr-2)+ Cells By Flow Cytometry; 30 Tests in 60 µL

Miltenyi Biotec Clone REA1046 recognizes the CD309 antigen, a transmembrane tyrosine kinase, also known as vascular endothelial growth factor receptor-2 (VEGFR-2) or kinase insert domain–containing receptor (KDR). CD309 is a high-affinity receptor for VEGF and plays a role in hematopoiesis. It is also involved in angiogenesis, both during embryogenesis and in the context of homeostatic or pathological events, e.g., vascularization of tumors. It has been identified on a subset of hematopoietic stem cells (HSCs), endothelial progenitor cells (EPCs), as well as on their common progenitor, the hemangioblast. CD309 expression is also found on mature endothelial cells (ECs). | Additional information: Clone REA1046 displays negligible binding to Fc receptors. - MLTY (Additional S&H or Hazmat Fees May Apply)